James A. Palmer

2.2k total citations · 1 hit paper
36 papers, 1.8k citations indexed

About

James A. Palmer is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, James A. Palmer has authored 36 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 9 papers in Molecular Biology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in James A. Palmer's work include Cannabis and Cannabinoid Research (16 papers), Alcohol Consumption and Health Effects (6 papers) and Pain Mechanisms and Treatments (4 papers). James A. Palmer is often cited by papers focused on Cannabis and Cannabinoid Research (16 papers), Alcohol Consumption and Health Effects (6 papers) and Pain Mechanisms and Treatments (4 papers). James A. Palmer collaborates with scholars based in United States, United Kingdom and Belgium. James A. Palmer's co-authors include Stephen P. Hunt, John O’Brien, Carmen De Felipe, Juan F. Herrero, Christopher A. Doyle, Jennifer M.A. Laird, Andrew J. H. Smith, Carlos Belmonte, Fernando Cerveró and Sandra R. Chaplan and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Virology.

In The Last Decade

James A. Palmer

33 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Altered nociception, analgesia and aggression in mice lacking the receptor for substance P

1998 620 citations Carmen De Felipe, Juan F. Herrero et al. Nature profile →

Peers

Countries citing papers authored by James A. Palmer

Since Specialization

Citations

This map shows the geographic impact of James A. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Palmer more than expected).

Fields of papers citing papers by James A. Palmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Palmer. The network helps show where James A. Palmer may publish in the future.

Co-authorship network of co-authors of James A. Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Palmer. A scholar is included among the top collaborators of James A. Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Palmer. James A. Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and safety of adjunctive treatment with the fatty acid amide hydrolase inhibitor JNJ-42165279 in participants with major depressive disorder with anxious distress: A double-blind, placebo-controlled, randomised study 2026 ·European Neuropsychopharmacology ·(unknown), Cynthia Gargano, Xianhuang Zhou, James A. Palmer, (unknown), (unknown), (unknown), Kim Stuyckens, (unknown)	0
2	Anti-seizure effects of JNJ-54175446 in the intra-amygdala kainic acid model of drug-resistant temporal lobe epilepsy in mice 2024 ·Frontiers in Pharmacology ·Omar Mamad, (unknown), Andreas U. Lindner, (unknown), (unknown), (unknown), Amaya Sanz‐Rodriguez, Elena Langa, J Heller, Óscar Moreno, Jordi Llop, Anindya Bhattacharya, James A. Palmer, Marc Ceusters, Tobías Engel, David C. Henshall	5
3	A Phase 1 First‐in‐Human Pharmacokinetic and Pharmacodynamic Study of JNJ‐64264681, a Covalent Inhibitor of Bruton's Tyrosine Kinase 2023 ·Clinical Pharmacology in Drug Development ·Jocelyn H. Leu, Xin Miao, Kevin Shalayda, Kevin J. Coe, Ariane Kahnt, Bonnie Wu, (unknown), (unknown), James J. Devlin, Tong‐Yuan Yang, James A. Palmer, Mai Zhang, Honghui Zhou, Wim Van Damme, (unknown), Zuleima Aguilar, Sandra R. Chaplan	2
4	The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study 2020 ·Neuropsychopharmacology ·Mark E. Schmidt, Michael R. Liebowitz, Murray B. Stein, Jennifer Grunfeld, Ilse Van Hove, W. Kyle Simmons, Peter van der Ark, James A. Palmer, Ziad S. Saad, Darrel J. Pemberton, Luc Van Nueten, Wayne C. Drevets	67
5	Heteroarylureas with fused bicyclic diamine cores as inhibitors of fatty acid amide hydrolase 2020 ·Bioorganic & Medicinal Chemistry Letters ·John M. Keith, W. M. Jones, (unknown), Mark Seierstad, James A. Palmer, Michael Webb, Mark J. Karbarz, Brian Scott, Sandy J. Wilson, Lin Luo, Michelle Wennerholm, Leon Chang, Michèle Rizzolio, (unknown), Sandra R. Chaplan, J. Guy Breitenbucher	4
6	The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·John M. Keith, Mark S. Tichenor, Richard L. Apodaca, Wei Xiao, W. M. Jones, Mark Seierstad, (unknown), James A. Palmer, Michael Webb, Mark J. Karbarz, Brian Scott, Sandy J. Wilson, Michelle Wennerholm, Michèle Rizzolio, (unknown), Sandra R. Chaplan, J. Guy Breitenbucher	11
7	Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase 2014 ·Bioorganic & Medicinal Chemistry Letters ·John M. Keith, W. M. Jones, (unknown), Mark Seierstad, James A. Palmer, Michael Webb, Mark J. Karbarz, Brian Scott, Sandy J. Wilson, Lin Luo, Michelle Wennerholm, Leon Chang, Sean M. Brown, Michèle Rizzolio, (unknown), Sandra R. Chaplan, J. Guy Breitenbucher	24
8	Heteroaryl urea inhibitors of fatty acid amide hydrolase: Structure–mutagenicity relationships for arylamine metabolites 2012 ·Bioorganic & Medicinal Chemistry Letters ·Mark S. Tichenor, John M. Keith, W. M. Jones, (unknown), (unknown), Natalie A. Hawryluk, Mark Seierstad, James A. Palmer, Michael Webb, Mark J. Karbarz, Sandy J. Wilson, Michelle Wennerholm, (unknown), D. Beerens, Lin Luo, Sean M. Brown, Marlies De Boeck, Sandra R. Chaplan, J. Guy Breitenbucher	20
9	The Role of Endocannabinoids in Pain Modulation and the Therapeutic Potential of Inhibiting their Enzymatic Degradation 2011 ·Current Pharmaceutical Biotechnology ·Lily Alvarez‐Jaimes, James A. Palmer	21
10	Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement 2010 ·Psychopharmacology ·James R. Shoblock, Natalie Welty, Leah Aluisio, Ian Fraser, S. Timothy Motley, (unknown), James A. Palmer, Pascal Bonaventure, Nicholas I. Carruthers, Timothy W. Lovenberg, Jamin D. Boggs, Ruggero Galici	128
11	Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase 2008 ·Anesthesia & Analgesia ·Mark J. Karbarz, Lin Luo, Leon Chang, Chui‐Se Tham, James A. Palmer, Sandy J. Wilson, Michelle Wennerholm, Sean M. Brown, Brian Scott, Richard L. Apodaca, John M. Keith, Jiejun Wu, J. Guy Breitenbucher, Sandra R. Chaplan, Michael Webb	61
12	Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase 2008 ·Bioorganic & Medicinal Chemistry Letters ·John M. Keith, Richard L. Apodaca, Wei Xiao, Mark Seierstad, Kanaka Pattabiraman, Jiejun Wu, Michael Webb, Mark J. Karbarz, Sean M. Brown, Sandy Wilson, Brian Scott, Chui‐Se Tham, Lin Luo, James A. Palmer, Michelle Wennerholm, Sandra R. Chaplan, J. Guy Breitenbucher	76
13	Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse 2008 ·Neuroscience ·James A. Palmer, Emiliano S. Higuera, Leon Chang, Sandra R. Chaplan	24
14	iNOS inhibition in acute migraine: pharmacokinetic characteristics, safety and tolerability of GW273629 2007 ·Cephalalgia ·Bart Van der Schueren, Martin W. Lunnon, Bart Laurijssens, (unknown), James A. Palmer, Marleen Depré, Anne Van Hecken, Floris Vanmolkot, Jan de Hoon	2
15	Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms 2006 ·British Journal of Pharmacology ·Leon Chang, Lin Luo, James A. Palmer, Steven W. Sutton, Sandy J. Wilson, Ann Barbier, J. Guy Breitenbucher, Sandra R. Chaplan, Michael Webb	139
16	Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo 2004 ·Gene Therapy ·(unknown), Stephen P. Hunt, R. S. Coffin, James A. Palmer	20
17	FLRT3 is expressed in sensory neurons after peripheral nerve injury and regulates neurite outgrowth 2004 ·Molecular and Cellular Neuroscience ·Mark W. Robinson, (unknown), (unknown), James A. Palmer, Anand G. Patel, Daniel L. Marks, Alexandre Sheasby, C. De Felipe, R. S. Coffin, Frederick J. Livesey, Stephen P. Hunt	40
18	Disruption of the substance P receptor (neurokinin‐1) gene does not prevent upregulation of preprotachykinin‐A mRNA in the spinal cord of mice following peripheral inflammation 1999 ·European Journal of Neuroscience ·James A. Palmer, Carmen De Felipe, John O’Brien, Stephen P. Hunt	6
19	Altered nociception, analgesia and aggression in mice lacking the receptor for substance P breakdown → 1998 ·Nature ·Carmen De Felipe, Juan F. Herrero, John O’Brien, James A. Palmer, Christopher A. Doyle, Andrew J. H. Smith, Jennifer M.A. Laird, Carlos Belmonte, Fernando Cerveró, Stephen P. Hunt	620
20	Fr. Georgius de Hungaria, O P., and the Tractatus de Moribus Condicionibus et Nequicia Turcorum 1951 ·Bulletin of the John Rylands Library ·James A. Palmer	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact